HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Chambers-Slater Selected Research

toralizumab

2/2001A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Chambers-Slater Research Topics

Disease

1Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2001

Drug/Important Bio-Agent (IBA)

1toralizumabIBA
02/2001

Therapy/Procedure

1Therapeutics
02/2001